nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbimazole—CYP19A1—prostate cancer	0.63	1	CbGaD
Carbimazole—CYP19A1—semen—prostate cancer	0.00712	0.547	CbGeAlD
Carbimazole—TPO—testis—prostate cancer	0.00276	0.212	CbGeAlD
Carbimazole—CYP19A1—prostate gland—prostate cancer	0.00178	0.137	CbGeAlD
Carbimazole—CYP19A1—testis—prostate cancer	0.000786	0.0604	CbGeAlD
Carbimazole—CYP19A1—lymph node—prostate cancer	0.00057	0.0438	CbGeAlD
Carbimazole—Hepatocellular injury—Epirubicin—prostate cancer	0.000361	0.00188	CcSEcCtD
Carbimazole—Urticaria—Ethinyl Estradiol—prostate cancer	0.000361	0.00188	CcSEcCtD
Carbimazole—Skin disorder—Conjugated Estrogens—prostate cancer	0.00036	0.00187	CcSEcCtD
Carbimazole—Body temperature increased—Ethinyl Estradiol—prostate cancer	0.000359	0.00187	CcSEcCtD
Carbimazole—Liver function test abnormal—Docetaxel—prostate cancer	0.000359	0.00187	CcSEcCtD
Carbimazole—Jaundice—Etoposide—prostate cancer	0.000351	0.00183	CcSEcCtD
Carbimazole—Stomatitis—Etoposide—prostate cancer	0.000351	0.00183	CcSEcCtD
Carbimazole—Liver function test abnormal—Capecitabine—prostate cancer	0.000347	0.00181	CcSEcCtD
Carbimazole—Alopecia—Mitoxantrone—prostate cancer	0.000344	0.00179	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Goserelin—prostate cancer	0.000341	0.00177	CcSEcCtD
Carbimazole—Rash—Bicalutamide—prostate cancer	0.000339	0.00177	CcSEcCtD
Carbimazole—Aplastic anaemia—Epirubicin—prostate cancer	0.000339	0.00177	CcSEcCtD
Carbimazole—Dermatitis—Bicalutamide—prostate cancer	0.000339	0.00176	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Conjugated Estrogens—prostate cancer	0.000338	0.00176	CcSEcCtD
Carbimazole—Ill-defined disorder—Estradiol—prostate cancer	0.000337	0.00176	CcSEcCtD
Carbimazole—Headache—Bicalutamide—prostate cancer	0.000337	0.00175	CcSEcCtD
Carbimazole—Agranulocytosis—Etoposide—prostate cancer	0.000336	0.00175	CcSEcCtD
Carbimazole—Hypersensitivity—Ethinyl Estradiol—prostate cancer	0.000335	0.00174	CcSEcCtD
Carbimazole—Hepatocellular injury—Doxorubicin—prostate cancer	0.000334	0.00174	CcSEcCtD
Carbimazole—Angioedema—Estradiol—prostate cancer	0.000332	0.00173	CcSEcCtD
Carbimazole—Malaise—Estradiol—prostate cancer	0.000328	0.00171	CcSEcCtD
Carbimazole—Mouth ulceration—Epirubicin—prostate cancer	0.000327	0.0017	CcSEcCtD
Carbimazole—Pruritus—Ethinyl Estradiol—prostate cancer	0.000322	0.00167	CcSEcCtD
Carbimazole—Nausea—Bicalutamide—prostate cancer	0.000319	0.00166	CcSEcCtD
Carbimazole—Pancytopenia—Docetaxel—prostate cancer	0.000319	0.00166	CcSEcCtD
Carbimazole—Ill-defined disorder—Mitoxantrone—prostate cancer	0.000314	0.00164	CcSEcCtD
Carbimazole—Neutropenia—Docetaxel—prostate cancer	0.000314	0.00164	CcSEcCtD
Carbimazole—Aplastic anaemia—Doxorubicin—prostate cancer	0.000314	0.00163	CcSEcCtD
Carbimazole—Arthralgia—Estradiol—prostate cancer	0.000309	0.00161	CcSEcCtD
Carbimazole—Myalgia—Estradiol—prostate cancer	0.000309	0.00161	CcSEcCtD
Carbimazole—Pancytopenia—Capecitabine—prostate cancer	0.000309	0.00161	CcSEcCtD
Carbimazole—Feeling abnormal—Goserelin—prostate cancer	0.000308	0.00161	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Estradiol—prostate cancer	0.000307	0.0016	CcSEcCtD
Carbimazole—Discomfort—Estradiol—prostate cancer	0.000306	0.00159	CcSEcCtD
Carbimazole—Malaise—Mitoxantrone—prostate cancer	0.000305	0.00159	CcSEcCtD
Carbimazole—Neutropenia—Capecitabine—prostate cancer	0.000304	0.00158	CcSEcCtD
Carbimazole—Leukopenia—Mitoxantrone—prostate cancer	0.000303	0.00158	CcSEcCtD
Carbimazole—Mouth ulceration—Doxorubicin—prostate cancer	0.000302	0.00157	CcSEcCtD
Carbimazole—Urticaria—Goserelin—prostate cancer	0.000297	0.00155	CcSEcCtD
Carbimazole—Body temperature increased—Goserelin—prostate cancer	0.000296	0.00154	CcSEcCtD
Carbimazole—Infection—Estradiol—prostate cancer	0.000295	0.00153	CcSEcCtD
Carbimazole—Urticaria—Conjugated Estrogens—prostate cancer	0.000294	0.00153	CcSEcCtD
Carbimazole—Angiopathy—Etoposide—prostate cancer	0.000294	0.00153	CcSEcCtD
Carbimazole—Body temperature increased—Conjugated Estrogens—prostate cancer	0.000293	0.00153	CcSEcCtD
Carbimazole—Jaundice—Docetaxel—prostate cancer	0.000292	0.00152	CcSEcCtD
Carbimazole—Stomatitis—Docetaxel—prostate cancer	0.000292	0.00152	CcSEcCtD
Carbimazole—Nervous system disorder—Estradiol—prostate cancer	0.000291	0.00151	CcSEcCtD
Carbimazole—Myalgia—Mitoxantrone—prostate cancer	0.000288	0.0015	CcSEcCtD
Carbimazole—Arthralgia—Mitoxantrone—prostate cancer	0.000288	0.0015	CcSEcCtD
Carbimazole—Skin disorder—Estradiol—prostate cancer	0.000288	0.0015	CcSEcCtD
Carbimazole—Rash—Ethinyl Estradiol—prostate cancer	0.000287	0.00149	CcSEcCtD
Carbimazole—Dermatitis—Ethinyl Estradiol—prostate cancer	0.000286	0.00149	CcSEcCtD
Carbimazole—Alopecia—Etoposide—prostate cancer	0.000286	0.00149	CcSEcCtD
Carbimazole—Discomfort—Mitoxantrone—prostate cancer	0.000285	0.00148	CcSEcCtD
Carbimazole—Headache—Ethinyl Estradiol—prostate cancer	0.000285	0.00148	CcSEcCtD
Carbimazole—Stomatitis—Capecitabine—prostate cancer	0.000283	0.00147	CcSEcCtD
Carbimazole—Jaundice—Capecitabine—prostate cancer	0.000283	0.00147	CcSEcCtD
Carbimazole—Agranulocytosis—Docetaxel—prostate cancer	0.000279	0.00146	CcSEcCtD
Carbimazole—Hypersensitivity—Goserelin—prostate cancer	0.000276	0.00144	CcSEcCtD
Carbimazole—Infection—Mitoxantrone—prostate cancer	0.000275	0.00143	CcSEcCtD
Carbimazole—Hypersensitivity—Conjugated Estrogens—prostate cancer	0.000273	0.00142	CcSEcCtD
Carbimazole—Neutropenia—Prednisone—prostate cancer	0.000271	0.00141	CcSEcCtD
Carbimazole—Agranulocytosis—Capecitabine—prostate cancer	0.000271	0.00141	CcSEcCtD
Carbimazole—Thrombocytopenia—Mitoxantrone—prostate cancer	0.000271	0.00141	CcSEcCtD
Carbimazole—Haemoglobin—Docetaxel—prostate cancer	0.00027	0.00141	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Estradiol—prostate cancer	0.00027	0.00141	CcSEcCtD
Carbimazole—Nausea—Ethinyl Estradiol—prostate cancer	0.00027	0.00141	CcSEcCtD
Carbimazole—Haemorrhage—Docetaxel—prostate cancer	0.000269	0.0014	CcSEcCtD
Carbimazole—Hepatitis—Docetaxel—prostate cancer	0.000269	0.0014	CcSEcCtD
Carbimazole—Skin disorder—Mitoxantrone—prostate cancer	0.000268	0.0014	CcSEcCtD
Carbimazole—Pruritus—Goserelin—prostate cancer	0.000265	0.00138	CcSEcCtD
Carbimazole—Pruritus—Conjugated Estrogens—prostate cancer	0.000262	0.00137	CcSEcCtD
Carbimazole—Haemoglobin—Capecitabine—prostate cancer	0.000262	0.00136	CcSEcCtD
Carbimazole—Ill-defined disorder—Etoposide—prostate cancer	0.000261	0.00136	CcSEcCtD
Carbimazole—Haemorrhage—Capecitabine—prostate cancer	0.00026	0.00136	CcSEcCtD
Carbimazole—Hepatitis—Capecitabine—prostate cancer	0.00026	0.00136	CcSEcCtD
Carbimazole—Malaise—Etoposide—prostate cancer	0.000254	0.00132	CcSEcCtD
Carbimazole—Leukopenia—Etoposide—prostate cancer	0.000252	0.00131	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Mitoxantrone—prostate cancer	0.000252	0.00131	CcSEcCtD
Carbimazole—Feeling abnormal—Estradiol—prostate cancer	0.000244	0.00127	CcSEcCtD
Carbimazole—Angiopathy—Docetaxel—prostate cancer	0.000244	0.00127	CcSEcCtD
Carbimazole—Liver function test abnormal—Epirubicin—prostate cancer	0.000242	0.00126	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Etoposide—prostate cancer	0.000238	0.00124	CcSEcCtD
Carbimazole—Alopecia—Docetaxel—prostate cancer	0.000238	0.00124	CcSEcCtD
Carbimazole—Discomfort—Etoposide—prostate cancer	0.000237	0.00123	CcSEcCtD
Carbimazole—Angiopathy—Capecitabine—prostate cancer	0.000236	0.00123	CcSEcCtD
Carbimazole—Rash—Goserelin—prostate cancer	0.000236	0.00123	CcSEcCtD
Carbimazole—Dermatitis—Goserelin—prostate cancer	0.000236	0.00123	CcSEcCtD
Carbimazole—Urticaria—Estradiol—prostate cancer	0.000236	0.00123	CcSEcCtD
Carbimazole—Body temperature increased—Estradiol—prostate cancer	0.000234	0.00122	CcSEcCtD
Carbimazole—Headache—Goserelin—prostate cancer	0.000234	0.00122	CcSEcCtD
Carbimazole—Rash—Conjugated Estrogens—prostate cancer	0.000234	0.00122	CcSEcCtD
Carbimazole—Dermatitis—Conjugated Estrogens—prostate cancer	0.000233	0.00122	CcSEcCtD
Carbimazole—Haemoglobin—Prednisone—prostate cancer	0.000233	0.00121	CcSEcCtD
Carbimazole—Headache—Conjugated Estrogens—prostate cancer	0.000232	0.00121	CcSEcCtD
Carbimazole—Haemorrhage—Prednisone—prostate cancer	0.000232	0.00121	CcSEcCtD
Carbimazole—Alopecia—Capecitabine—prostate cancer	0.00023	0.0012	CcSEcCtD
Carbimazole—Infection—Etoposide—prostate cancer	0.000228	0.00119	CcSEcCtD
Carbimazole—Feeling abnormal—Mitoxantrone—prostate cancer	0.000228	0.00119	CcSEcCtD
Carbimazole—Thrombocytopenia—Etoposide—prostate cancer	0.000225	0.00117	CcSEcCtD
Carbimazole—Eosinophilia—Epirubicin—prostate cancer	0.000224	0.00117	CcSEcCtD
Carbimazole—Liver function test abnormal—Doxorubicin—prostate cancer	0.000224	0.00117	CcSEcCtD
Carbimazole—Skin disorder—Etoposide—prostate cancer	0.000223	0.00116	CcSEcCtD
Carbimazole—Nausea—Goserelin—prostate cancer	0.000222	0.00116	CcSEcCtD
Carbimazole—Nausea—Conjugated Estrogens—prostate cancer	0.00022	0.00115	CcSEcCtD
Carbimazole—Urticaria—Mitoxantrone—prostate cancer	0.00022	0.00114	CcSEcCtD
Carbimazole—Hypersensitivity—Estradiol—prostate cancer	0.000218	0.00114	CcSEcCtD
Carbimazole—Body temperature increased—Mitoxantrone—prostate cancer	0.000218	0.00114	CcSEcCtD
Carbimazole—Pancytopenia—Epirubicin—prostate cancer	0.000215	0.00112	CcSEcCtD
Carbimazole—Neutropenia—Epirubicin—prostate cancer	0.000212	0.0011	CcSEcCtD
Carbimazole—Angiopathy—Prednisone—prostate cancer	0.00021	0.0011	CcSEcCtD
Carbimazole—Ill-defined disorder—Capecitabine—prostate cancer	0.00021	0.00109	CcSEcCtD
Carbimazole—Pruritus—Estradiol—prostate cancer	0.00021	0.00109	CcSEcCtD
Carbimazole—Leukopenia—Docetaxel—prostate cancer	0.00021	0.00109	CcSEcCtD
Carbimazole—Eosinophilia—Doxorubicin—prostate cancer	0.000208	0.00108	CcSEcCtD
Carbimazole—Alopecia—Prednisone—prostate cancer	0.000205	0.00107	CcSEcCtD
Carbimazole—Malaise—Capecitabine—prostate cancer	0.000204	0.00106	CcSEcCtD
Carbimazole—Hypersensitivity—Mitoxantrone—prostate cancer	0.000204	0.00106	CcSEcCtD
Carbimazole—Leukopenia—Capecitabine—prostate cancer	0.000203	0.00106	CcSEcCtD
Carbimazole—Arthralgia—Docetaxel—prostate cancer	0.000199	0.00104	CcSEcCtD
Carbimazole—Myalgia—Docetaxel—prostate cancer	0.000199	0.00104	CcSEcCtD
Carbimazole—Pancytopenia—Doxorubicin—prostate cancer	0.000199	0.00104	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—prostate cancer	0.000198	0.00103	CcSEcCtD
Carbimazole—Jaundice—Epirubicin—prostate cancer	0.000197	0.00103	CcSEcCtD
Carbimazole—Stomatitis—Epirubicin—prostate cancer	0.000197	0.00103	CcSEcCtD
Carbimazole—Neutropenia—Doxorubicin—prostate cancer	0.000196	0.00102	CcSEcCtD
Carbimazole—Arthralgia—Capecitabine—prostate cancer	0.000193	0.001	CcSEcCtD
Carbimazole—Myalgia—Capecitabine—prostate cancer	0.000193	0.001	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	0.000192	0.000998	CcSEcCtD
Carbimazole—Discomfort—Capecitabine—prostate cancer	0.000191	0.000992	CcSEcCtD
Carbimazole—Infection—Docetaxel—prostate cancer	0.00019	0.000988	CcSEcCtD
Carbimazole—Feeling abnormal—Etoposide—prostate cancer	0.000189	0.000986	CcSEcCtD
Carbimazole—Agranulocytosis—Epirubicin—prostate cancer	0.000189	0.000982	CcSEcCtD
Carbimazole—Nervous system disorder—Docetaxel—prostate cancer	0.000187	0.000975	CcSEcCtD
Carbimazole—Ill-defined disorder—Prednisone—prostate cancer	0.000187	0.000975	CcSEcCtD
Carbimazole—Thrombocytopenia—Docetaxel—prostate cancer	0.000187	0.000974	CcSEcCtD
Carbimazole—Rash—Estradiol—prostate cancer	0.000187	0.000974	CcSEcCtD
Carbimazole—Dermatitis—Estradiol—prostate cancer	0.000187	0.000973	CcSEcCtD
Carbimazole—Headache—Estradiol—prostate cancer	0.000186	0.000967	CcSEcCtD
Carbimazole—Skin disorder—Docetaxel—prostate cancer	0.000186	0.000966	CcSEcCtD
Carbimazole—Angioedema—Prednisone—prostate cancer	0.000184	0.00096	CcSEcCtD
Carbimazole—Infection—Capecitabine—prostate cancer	0.000184	0.000957	CcSEcCtD
Carbimazole—Urticaria—Etoposide—prostate cancer	0.000183	0.000951	CcSEcCtD
Carbimazole—Haemoglobin—Epirubicin—prostate cancer	0.000182	0.000949	CcSEcCtD
Carbimazole—Jaundice—Doxorubicin—prostate cancer	0.000182	0.000949	CcSEcCtD
Carbimazole—Stomatitis—Doxorubicin—prostate cancer	0.000182	0.000949	CcSEcCtD
Carbimazole—Malaise—Prednisone—prostate cancer	0.000182	0.000948	CcSEcCtD
Carbimazole—Body temperature increased—Etoposide—prostate cancer	0.000182	0.000946	CcSEcCtD
Carbimazole—Nervous system disorder—Capecitabine—prostate cancer	0.000181	0.000944	CcSEcCtD
Carbimazole—Hepatitis—Epirubicin—prostate cancer	0.000181	0.000944	CcSEcCtD
Carbimazole—Haemorrhage—Epirubicin—prostate cancer	0.000181	0.000944	CcSEcCtD
Carbimazole—Thrombocytopenia—Capecitabine—prostate cancer	0.000181	0.000943	CcSEcCtD
Carbimazole—Skin disorder—Capecitabine—prostate cancer	0.00018	0.000935	CcSEcCtD
Carbimazole—Nausea—Estradiol—prostate cancer	0.000176	0.000917	CcSEcCtD
Carbimazole—Agranulocytosis—Doxorubicin—prostate cancer	0.000174	0.000908	CcSEcCtD
Carbimazole—Rash—Mitoxantrone—prostate cancer	0.000174	0.000907	CcSEcCtD
Carbimazole—Dermatitis—Mitoxantrone—prostate cancer	0.000174	0.000906	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Docetaxel—prostate cancer	0.000174	0.000906	CcSEcCtD
Carbimazole—Headache—Mitoxantrone—prostate cancer	0.000173	0.000901	CcSEcCtD
Carbimazole—Myalgia—Prednisone—prostate cancer	0.000172	0.000895	CcSEcCtD
Carbimazole—Arthralgia—Prednisone—prostate cancer	0.000172	0.000895	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	0.000171	0.000889	CcSEcCtD
Carbimazole—Discomfort—Prednisone—prostate cancer	0.00017	0.000884	CcSEcCtD
Carbimazole—Hypersensitivity—Etoposide—prostate cancer	0.000169	0.000882	CcSEcCtD
Carbimazole—Haemoglobin—Doxorubicin—prostate cancer	0.000169	0.000878	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Capecitabine—prostate cancer	0.000168	0.000877	CcSEcCtD
Carbimazole—Haemorrhage—Doxorubicin—prostate cancer	0.000168	0.000874	CcSEcCtD
Carbimazole—Hepatitis—Doxorubicin—prostate cancer	0.000168	0.000874	CcSEcCtD
Carbimazole—Angiopathy—Epirubicin—prostate cancer	0.000165	0.000857	CcSEcCtD
Carbimazole—TPO—Metabolism—CYP3A5—prostate cancer	0.000165	0.000996	CbGpPWpGaD
Carbimazole—Nausea—Mitoxantrone—prostate cancer	0.000164	0.000855	CcSEcCtD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—CASP9—prostate cancer	0.000164	0.000992	CbGpPWpGaD
Carbimazole—Infection—Prednisone—prostate cancer	0.000164	0.000852	CcSEcCtD
Carbimazole—Pruritus—Etoposide—prostate cancer	0.000163	0.000847	CcSEcCtD
Carbimazole—Nervous system disorder—Prednisone—prostate cancer	0.000162	0.000841	CcSEcCtD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—HSD17B1—prostate cancer	0.000161	0.000974	CbGpPWpGaD
Carbimazole—Alopecia—Epirubicin—prostate cancer	0.00016	0.000834	CcSEcCtD
Carbimazole—Skin disorder—Prednisone—prostate cancer	0.00016	0.000833	CcSEcCtD
Carbimazole—TPO—Metabolism—PDHA1—prostate cancer	0.000159	0.000962	CbGpPWpGaD
Carbimazole—TPO—Metabolism—TCN2—prostate cancer	0.000159	0.000962	CbGpPWpGaD
Carbimazole—TPO—Metabolism—GSTA3—prostate cancer	0.000159	0.000962	CbGpPWpGaD
Carbimazole—TPO—Metabolism—UCP3—prostate cancer	0.000159	0.000962	CbGpPWpGaD
Carbimazole—Feeling abnormal—Docetaxel—prostate cancer	0.000157	0.00082	CcSEcCtD
Carbimazole—CYP19A1—Biological oxidations—CYP2E1—prostate cancer	0.000157	0.00095	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—BRCA1—prostate cancer	0.000155	0.000939	CbGpPWpGaD
Carbimazole—CYP19A1—Metapathway biotransformation—CYP2E1—prostate cancer	0.000155	0.000937	CbGpPWpGaD
Carbimazole—Feeling abnormal—Capecitabine—prostate cancer	0.000152	0.000794	CcSEcCtD
Carbimazole—Angiopathy—Doxorubicin—prostate cancer	0.000152	0.000793	CcSEcCtD
Carbimazole—TPO—Metabolism—SLC22A3—prostate cancer	0.000152	0.000917	CbGpPWpGaD
Carbimazole—TPO—Metabolism—HSD3B1—prostate cancer	0.000152	0.000917	CbGpPWpGaD
Carbimazole—CYP19A1—Biological oxidations—CYP3A4—prostate cancer	0.000151	0.000916	CbGpPWpGaD
Carbimazole—Body temperature increased—Docetaxel—prostate cancer	0.000151	0.000786	CcSEcCtD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—AR—prostate cancer	0.000151	0.000914	CbGpPWpGaD
Carbimazole—Musculoskeletal discomfort—Prednisone—prostate cancer	0.00015	0.000781	CcSEcCtD
Carbimazole—CYP19A1—Metapathway biotransformation—CYP3A4—prostate cancer	0.000149	0.000903	CbGpPWpGaD
Carbimazole—CYP19A1—Biological oxidations—CYP1B1—prostate cancer	0.000149	0.0009	CbGpPWpGaD
Carbimazole—Alopecia—Doxorubicin—prostate cancer	0.000148	0.000772	CcSEcCtD
Carbimazole—CYP19A1—FSH signaling pathway—AKT1—prostate cancer	0.000148	0.000897	CbGpPWpGaD
Carbimazole—Urticaria—Capecitabine—prostate cancer	0.000147	0.000765	CcSEcCtD
Carbimazole—CYP19A1—Metapathway biotransformation—CYP1B1—prostate cancer	0.000147	0.000888	CbGpPWpGaD
Carbimazole—Ill-defined disorder—Epirubicin—prostate cancer	0.000146	0.000763	CcSEcCtD
Carbimazole—Body temperature increased—Capecitabine—prostate cancer	0.000146	0.000761	CcSEcCtD
Carbimazole—TPO—Metabolism—GSTA4—prostate cancer	0.000145	0.000879	CbGpPWpGaD
Carbimazole—TPO—Metabolism—TBXAS1—prostate cancer	0.000145	0.000879	CbGpPWpGaD
Carbimazole—Rash—Etoposide—prostate cancer	0.000145	0.000755	CcSEcCtD
Carbimazole—Dermatitis—Etoposide—prostate cancer	0.000145	0.000754	CcSEcCtD
Carbimazole—CYP19A1—Biological oxidations—GGT1—prostate cancer	0.000144	0.000872	CbGpPWpGaD
Carbimazole—Headache—Etoposide—prostate cancer	0.000144	0.00075	CcSEcCtD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—TGFBR2—prostate cancer	0.000144	0.000869	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—HPGD—prostate cancer	0.000143	0.000868	CbGpPWpGaD
Carbimazole—Malaise—Epirubicin—prostate cancer	0.000142	0.000741	CcSEcCtD
Carbimazole—CYP19A1—Biological oxidations—NCOA1—prostate cancer	0.000142	0.000859	CbGpPWpGaD
Carbimazole—TPO—Metabolism—GSTA2—prostate cancer	0.000142	0.000857	CbGpPWpGaD
Carbimazole—Leukopenia—Epirubicin—prostate cancer	0.000141	0.000736	CcSEcCtD
Carbimazole—Hypersensitivity—Docetaxel—prostate cancer	0.000141	0.000733	CcSEcCtD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—BRCA2—prostate cancer	0.00014	0.000849	CbGpPWpGaD
Carbimazole—TPO—Metabolism—ABCG5—prostate cancer	0.00014	0.000847	CbGpPWpGaD
Carbimazole—TPO—Metabolism—SULT1A1—prostate cancer	0.00014	0.000847	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—SIRT1—prostate cancer	0.000138	0.000833	CbGpPWpGaD
Carbimazole—TPO—Metabolism—GSTA1—prostate cancer	0.000137	0.000827	CbGpPWpGaD
Carbimazole—Nausea—Etoposide—prostate cancer	0.000137	0.000711	CcSEcCtD
Carbimazole—Hypersensitivity—Capecitabine—prostate cancer	0.000136	0.000709	CcSEcCtD
Carbimazole—Feeling abnormal—Prednisone—prostate cancer	0.000136	0.000707	CcSEcCtD
Carbimazole—Ill-defined disorder—Doxorubicin—prostate cancer	0.000136	0.000706	CcSEcCtD
Carbimazole—Pruritus—Docetaxel—prostate cancer	0.000135	0.000704	CcSEcCtD
Carbimazole—TPO—Metabolism—HSD3B2—prostate cancer	0.000135	0.000818	CbGpPWpGaD
Carbimazole—TPO—Metabolism—GSTO1—prostate cancer	0.000135	0.000818	CbGpPWpGaD
Carbimazole—TPO—Metabolism—NAT2—prostate cancer	0.000135	0.000818	CbGpPWpGaD
Carbimazole—CYP19A1—Biological oxidations—RXRA—prostate cancer	0.000135	0.000817	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—TNFRSF21—prostate cancer	0.000135	0.000816	CbGpPWpGaD
Carbimazole—Myalgia—Epirubicin—prostate cancer	0.000134	0.0007	CcSEcCtD
Carbimazole—Arthralgia—Epirubicin—prostate cancer	0.000134	0.0007	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	0.000133	0.000695	CcSEcCtD
Carbimazole—Discomfort—Epirubicin—prostate cancer	0.000133	0.000691	CcSEcCtD
Carbimazole—Malaise—Doxorubicin—prostate cancer	0.000132	0.000686	CcSEcCtD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—CYP7B1—prostate cancer	0.000131	0.000794	CbGpPWpGaD
Carbimazole—Urticaria—Prednisone—prostate cancer	0.000131	0.000681	CcSEcCtD
Carbimazole—Pruritus—Capecitabine—prostate cancer	0.000131	0.000681	CcSEcCtD
Carbimazole—Leukopenia—Doxorubicin—prostate cancer	0.000131	0.000681	CcSEcCtD
Carbimazole—Body temperature increased—Prednisone—prostate cancer	0.00013	0.000678	CcSEcCtD
Carbimazole—CYP19A1—Biological oxidations—COMT—prostate cancer	0.00013	0.000787	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PLCB2—prostate cancer	0.00013	0.000784	CbGpPWpGaD
Carbimazole—TPO—Metabolism—CYP2C18—prostate cancer	0.00013	0.000784	CbGpPWpGaD
Carbimazole—TPO—Metabolism—LRP2—prostate cancer	0.00013	0.000784	CbGpPWpGaD
Carbimazole—CYP19A1—Biological oxidations—GSTP1—prostate cancer	0.000129	0.000783	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—BAX—prostate cancer	0.000129	0.000778	CbGpPWpGaD
Carbimazole—CYP19A1—Metapathway biotransformation—COMT—prostate cancer	0.000128	0.000776	CbGpPWpGaD
Carbimazole—Infection—Epirubicin—prostate cancer	0.000128	0.000666	CcSEcCtD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—SRD5A1—prostate cancer	0.000128	0.000774	CbGpPWpGaD
Carbimazole—CYP19A1—Metapathway biotransformation—GSTP1—prostate cancer	0.000128	0.000772	CbGpPWpGaD
Carbimazole—TPO—Metabolism—P4HB—prostate cancer	0.000127	0.000769	CbGpPWpGaD
Carbimazole—Nervous system disorder—Epirubicin—prostate cancer	0.000126	0.000658	CcSEcCtD
Carbimazole—Thrombocytopenia—Epirubicin—prostate cancer	0.000126	0.000657	CcSEcCtD
Carbimazole—Skin disorder—Epirubicin—prostate cancer	0.000125	0.000652	CcSEcCtD
Carbimazole—Myalgia—Doxorubicin—prostate cancer	0.000124	0.000648	CcSEcCtD
Carbimazole—Arthralgia—Doxorubicin—prostate cancer	0.000124	0.000648	CcSEcCtD
Carbimazole—TPO—Metabolism—SLC22A1—prostate cancer	0.000124	0.000748	CbGpPWpGaD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	0.000124	0.000643	CcSEcCtD
Carbimazole—Discomfort—Doxorubicin—prostate cancer	0.000123	0.00064	CcSEcCtD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—ACSL4—prostate cancer	0.000122	0.000738	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—HSD17B3—prostate cancer	0.000122	0.000738	CbGpPWpGaD
Carbimazole—Hypersensitivity—Prednisone—prostate cancer	0.000121	0.000632	CcSEcCtD
Carbimazole—Rash—Docetaxel—prostate cancer	0.00012	0.000627	CcSEcCtD
Carbimazole—TPO—Metabolism—SULT2A1—prostate cancer	0.00012	0.000729	CbGpPWpGaD
Carbimazole—Dermatitis—Docetaxel—prostate cancer	0.00012	0.000627	CcSEcCtD
Carbimazole—Headache—Docetaxel—prostate cancer	0.00012	0.000623	CcSEcCtD
Carbimazole—CYP19A1—Biological oxidations—GSTM1—prostate cancer	0.000119	0.00072	CbGpPWpGaD
Carbimazole—TPO—Metabolism—MED12—prostate cancer	0.000118	0.000717	CbGpPWpGaD
Carbimazole—Infection—Doxorubicin—prostate cancer	0.000118	0.000617	CcSEcCtD
Carbimazole—TPO—Metabolism—GNG5—prostate cancer	0.000118	0.000711	CbGpPWpGaD
Carbimazole—Musculoskeletal discomfort—Epirubicin—prostate cancer	0.000117	0.000611	CcSEcCtD
Carbimazole—CYP19A1—Metapathway biotransformation—GSTM1—prostate cancer	0.000117	0.00071	CbGpPWpGaD
Carbimazole—Nervous system disorder—Doxorubicin—prostate cancer	0.000117	0.000609	CcSEcCtD
Carbimazole—Thrombocytopenia—Doxorubicin—prostate cancer	0.000117	0.000608	CcSEcCtD
Carbimazole—Rash—Capecitabine—prostate cancer	0.000117	0.000607	CcSEcCtD
Carbimazole—Pruritus—Prednisone—prostate cancer	0.000117	0.000607	CcSEcCtD
Carbimazole—Dermatitis—Capecitabine—prostate cancer	0.000117	0.000607	CcSEcCtD
Carbimazole—Headache—Capecitabine—prostate cancer	0.000116	0.000603	CcSEcCtD
Carbimazole—Skin disorder—Doxorubicin—prostate cancer	0.000116	0.000603	CcSEcCtD
Carbimazole—Nausea—Docetaxel—prostate cancer	0.000113	0.000591	CcSEcCtD
Carbimazole—TPO—Metabolism—NCOA3—prostate cancer	0.000113	0.000685	CbGpPWpGaD
Carbimazole—CYP19A1—Biological oxidations—CYP1A1—prostate cancer	0.000113	0.000682	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—HAO1—prostate cancer	0.000111	0.000673	CbGpPWpGaD
Carbimazole—CYP19A1—Metapathway biotransformation—CYP1A1—prostate cancer	0.000111	0.000673	CbGpPWpGaD
Carbimazole—Nausea—Capecitabine—prostate cancer	0.00011	0.000572	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Doxorubicin—prostate cancer	0.000109	0.000566	CcSEcCtD
Carbimazole—TPO—Metabolism—HPGDS—prostate cancer	0.000108	0.000654	CbGpPWpGaD
Carbimazole—TPO—Metabolism—CYP2C19—prostate cancer	0.000107	0.00065	CbGpPWpGaD
Carbimazole—Feeling abnormal—Epirubicin—prostate cancer	0.000106	0.000553	CcSEcCtD
Carbimazole—TPO—Metabolism—ACHE—prostate cancer	0.000105	0.000634	CbGpPWpGaD
Carbimazole—TPO—Metabolism—GSTT1—prostate cancer	0.000105	0.000634	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—ATM—prostate cancer	0.000105	0.000633	CbGpPWpGaD
Carbimazole—Rash—Prednisone—prostate cancer	0.000104	0.000541	CcSEcCtD
Carbimazole—Dermatitis—Prednisone—prostate cancer	0.000104	0.00054	CcSEcCtD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—HSD3B1—prostate cancer	0.000104	0.000628	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—ESR1—prostate cancer	0.000104	0.000627	CbGpPWpGaD
Carbimazole—TPO—Metabolism—CYP2A6—prostate cancer	0.000104	0.000627	CbGpPWpGaD
Carbimazole—Headache—Prednisone—prostate cancer	0.000103	0.000537	CcSEcCtD
Carbimazole—Urticaria—Epirubicin—prostate cancer	0.000102	0.000533	CcSEcCtD
Carbimazole—Body temperature increased—Epirubicin—prostate cancer	0.000102	0.00053	CcSEcCtD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—BAD—prostate cancer	0.000101	0.000612	CbGpPWpGaD
Carbimazole—TPO—Metabolism—AKR1C3—prostate cancer	0.000101	0.00061	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PRKACB—prostate cancer	0.0001	0.000606	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—TBXAS1—prostate cancer	9.95e-05	0.000602	CbGpPWpGaD
Carbimazole—TPO—Metabolism—CYP17A1—prostate cancer	9.92e-05	0.0006	CbGpPWpGaD
Carbimazole—Feeling abnormal—Doxorubicin—prostate cancer	9.82e-05	0.000512	CcSEcCtD
Carbimazole—Nausea—Prednisone—prostate cancer	9.79e-05	0.00051	CcSEcCtD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—IRS1—prostate cancer	9.69e-05	0.000586	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—ABCG5—prostate cancer	9.57e-05	0.000579	CbGpPWpGaD
Carbimazole—Hypersensitivity—Epirubicin—prostate cancer	9.49e-05	0.000494	CcSEcCtD
Carbimazole—Urticaria—Doxorubicin—prostate cancer	9.47e-05	0.000493	CcSEcCtD
Carbimazole—TPO—Metabolism—NCOA2—prostate cancer	9.45e-05	0.000572	CbGpPWpGaD
Carbimazole—Body temperature increased—Doxorubicin—prostate cancer	9.42e-05	0.000491	CcSEcCtD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—HSD3B2—prostate cancer	9.25e-05	0.00056	CbGpPWpGaD
Carbimazole—Pruritus—Epirubicin—prostate cancer	9.12e-05	0.000475	CcSEcCtD
Carbimazole—CYP19A1—Metabolism—TST—prostate cancer	9.07e-05	0.000549	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—GRHL1—prostate cancer	9.07e-05	0.000549	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—CSAD—prostate cancer	9.07e-05	0.000549	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PSAT1—prostate cancer	9.07e-05	0.000549	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—ADI1—prostate cancer	9.07e-05	0.000549	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—CBR1—prostate cancer	9.07e-05	0.000549	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—CDH1—prostate cancer	9.02e-05	0.000546	CbGpPWpGaD
Carbimazole—TPO—Metabolism—SLC5A5—prostate cancer	9.02e-05	0.000546	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—LRP2—prostate cancer	8.87e-05	0.000536	CbGpPWpGaD
Carbimazole—TPO—Metabolism—CYP2E1—prostate cancer	8.81e-05	0.000533	CbGpPWpGaD
Carbimazole—Hypersensitivity—Doxorubicin—prostate cancer	8.78e-05	0.000457	CcSEcCtD
Carbimazole—TPO—Metabolism—NQO1—prostate cancer	8.71e-05	0.000527	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—P4HB—prostate cancer	8.69e-05	0.000526	CbGpPWpGaD
Carbimazole—TPO—Metabolism—TH—prostate cancer	8.58e-05	0.000519	CbGpPWpGaD
Carbimazole—TPO—Metabolism—CYP3A4—prostate cancer	8.49e-05	0.000514	CbGpPWpGaD
Carbimazole—Pruritus—Doxorubicin—prostate cancer	8.43e-05	0.000439	CcSEcCtD
Carbimazole—CYP19A1—Metabolism—UGT2B17—prostate cancer	8.43e-05	0.00051	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—CKMT2—prostate cancer	8.43e-05	0.00051	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—GRHPR—prostate cancer	8.43e-05	0.00051	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—UGT2B15—prostate cancer	8.43e-05	0.00051	CbGpPWpGaD
Carbimazole—TPO—Metabolism—CYP1B1—prostate cancer	8.35e-05	0.000505	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—SULT2A1—prostate cancer	8.24e-05	0.000499	CbGpPWpGaD
Carbimazole—Rash—Epirubicin—prostate cancer	8.12e-05	0.000423	CcSEcCtD
Carbimazole—Dermatitis—Epirubicin—prostate cancer	8.12e-05	0.000423	CcSEcCtD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—MED12—prostate cancer	8.11e-05	0.000491	CbGpPWpGaD
Carbimazole—TPO—Metabolism—GGT1—prostate cancer	8.08e-05	0.000489	CbGpPWpGaD
Carbimazole—Headache—Epirubicin—prostate cancer	8.07e-05	0.00042	CcSEcCtD
Carbimazole—TPO—Metabolism—NCOA1—prostate cancer	7.96e-05	0.000482	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—NAGLU—prostate cancer	7.93e-05	0.00048	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—RFK—prostate cancer	7.93e-05	0.00048	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—SULT2B1—prostate cancer	7.93e-05	0.00048	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—MBTPS1—prostate cancer	7.93e-05	0.00048	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—AOX1—prostate cancer	7.93e-05	0.00048	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PGAM2—prostate cancer	7.93e-05	0.00048	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—GSTM3—prostate cancer	7.93e-05	0.00048	CbGpPWpGaD
Carbimazole—TPO—Metabolism—CYP19A1—prostate cancer	7.85e-05	0.000475	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—BCL2—prostate cancer	7.83e-05	0.000474	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—NCOA3—prostate cancer	7.75e-05	0.000469	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—MDM2—prostate cancer	7.72e-05	0.000467	CbGpPWpGaD
Carbimazole—Nausea—Epirubicin—prostate cancer	7.65e-05	0.000398	CcSEcCtD
Carbimazole—TPO—Metabolism—RXRA—prostate cancer	7.57e-05	0.000458	CbGpPWpGaD
Carbimazole—Rash—Doxorubicin—prostate cancer	7.52e-05	0.000391	CcSEcCtD
Carbimazole—CYP19A1—Metabolism—CYP3A43—prostate cancer	7.52e-05	0.000455	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—AMACR—prostate cancer	7.52e-05	0.000455	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—SRD5A2—prostate cancer	7.52e-05	0.000455	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—NAT1—prostate cancer	7.52e-05	0.000455	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—DEGS1—prostate cancer	7.52e-05	0.000455	CbGpPWpGaD
Carbimazole—Dermatitis—Doxorubicin—prostate cancer	7.51e-05	0.000391	CcSEcCtD
Carbimazole—Headache—Doxorubicin—prostate cancer	7.47e-05	0.000389	CcSEcCtD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—HPGDS—prostate cancer	7.39e-05	0.000447	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—CYP2C19—prostate cancer	7.35e-05	0.000445	CbGpPWpGaD
Carbimazole—TPO—Metabolism—COMT—prostate cancer	7.3e-05	0.000442	CbGpPWpGaD
Carbimazole—TPO—Metabolism—GSTP1—prostate cancer	7.26e-05	0.000439	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—HSD17B1—prostate cancer	7.17e-05	0.000434	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—ACHE—prostate cancer	7.17e-05	0.000434	CbGpPWpGaD
Carbimazole—TPO—Metabolism—ITPR1—prostate cancer	7.15e-05	0.000432	CbGpPWpGaD
Carbimazole—Nausea—Doxorubicin—prostate cancer	7.08e-05	0.000369	CcSEcCtD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—CASP3—prostate cancer	6.91e-05	0.000418	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—AKR1C3—prostate cancer	6.89e-05	0.000417	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—PRKACB—prostate cancer	6.86e-05	0.000415	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—CYP17A1—prostate cancer	6.79e-05	0.000411	CbGpPWpGaD
Carbimazole—TPO—Metabolism—TYMS—prostate cancer	6.75e-05	0.000409	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—CCND1—prostate cancer	6.72e-05	0.000407	CbGpPWpGaD
Carbimazole—TPO—Metabolism—GSTM1—prostate cancer	6.67e-05	0.000404	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—CTNNB1—prostate cancer	6.66e-05	0.000403	CbGpPWpGaD
Carbimazole—TPO—Metabolism—LPL—prostate cancer	6.55e-05	0.000396	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—PTEN—prostate cancer	6.49e-05	0.000393	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—NCOA2—prostate cancer	6.47e-05	0.000391	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—B4GALT4—prostate cancer	6.39e-05	0.000387	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—HPGD—prostate cancer	6.39e-05	0.000387	CbGpPWpGaD
Carbimazole—TPO—Metabolism—CYP1A1—prostate cancer	6.33e-05	0.000383	CbGpPWpGaD
Carbimazole—TPO—Metabolism—ERCC2—prostate cancer	6.27e-05	0.00038	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—EP300—prostate cancer	6.19e-05	0.000374	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—TNFRSF21—prostate cancer	6.01e-05	0.000364	CbGpPWpGaD
Carbimazole—TPO—Metabolism—MTHFR—prostate cancer	5.9e-05	0.000357	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—prostate cancer	5.86e-05	0.000355	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—CYP7B1—prostate cancer	5.84e-05	0.000354	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—MTAP—prostate cancer	5.84e-05	0.000354	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PPARA—prostate cancer	5.79e-05	0.00035	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—CYP1B1—prostate cancer	5.71e-05	0.000346	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—SULT1E1—prostate cancer	5.7e-05	0.000345	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—SRD5A1—prostate cancer	5.7e-05	0.000345	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—GGT1—prostate cancer	5.53e-05	0.000335	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—NCOA1—prostate cancer	5.45e-05	0.00033	CbGpPWpGaD
Carbimazole—TPO—Metabolism—CAV1—prostate cancer	5.44e-05	0.000329	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—ACSL4—prostate cancer	5.43e-05	0.000329	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—HSD17B3—prostate cancer	5.43e-05	0.000329	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—MYC—prostate cancer	5.39e-05	0.000326	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—EGFR—prostate cancer	5.27e-05	0.000319	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PHGDH—prostate cancer	5.21e-05	0.000315	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—UMPS—prostate cancer	5.21e-05	0.000315	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—ARG2—prostate cancer	5.21e-05	0.000315	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—RXRA—prostate cancer	5.18e-05	0.000314	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—LDHB—prostate cancer	5.11e-05	0.000309	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—CYP3A5—prostate cancer	5.01e-05	0.000303	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—KRAS—prostate cancer	4.98e-05	0.000302	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PIK3CG—prostate cancer	4.96e-05	0.0003	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PDHA1—prostate cancer	4.84e-05	0.000293	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—GSTA3—prostate cancer	4.84e-05	0.000293	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—UCP3—prostate cancer	4.84e-05	0.000293	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—TCN2—prostate cancer	4.84e-05	0.000293	CbGpPWpGaD
Carbimazole—TPO—Metabolism—INS—prostate cancer	4.69e-05	0.000284	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—HSD3B1—prostate cancer	4.62e-05	0.00028	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—SLC22A3—prostate cancer	4.62e-05	0.00028	CbGpPWpGaD
Carbimazole—TPO—Metabolism—CREBBP—prostate cancer	4.59e-05	0.000278	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—LPL—prostate cancer	4.48e-05	0.000271	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—GSTA4—prostate cancer	4.43e-05	0.000268	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—TBXAS1—prostate cancer	4.43e-05	0.000268	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—TP53—prostate cancer	4.43e-05	0.000268	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PIK3CD—prostate cancer	4.36e-05	0.000264	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	4.33e-05	0.000262	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—GSTA2—prostate cancer	4.32e-05	0.000261	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—SULT1A1—prostate cancer	4.26e-05	0.000258	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—ABCG5—prostate cancer	4.26e-05	0.000258	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—GSTA1—prostate cancer	4.16e-05	0.000252	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—NAT2—prostate cancer	4.12e-05	0.000249	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—HSD3B2—prostate cancer	4.12e-05	0.000249	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—GSTO1—prostate cancer	4.12e-05	0.000249	CbGpPWpGaD
Carbimazole—TPO—Metabolism—NOS3—prostate cancer	4.11e-05	0.000249	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	3.96e-05	0.00024	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PLCB2—prostate cancer	3.95e-05	0.000239	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—LRP2—prostate cancer	3.95e-05	0.000239	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—CYP2C18—prostate cancer	3.95e-05	0.000239	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—P4HB—prostate cancer	3.87e-05	0.000234	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PIK3CB—prostate cancer	3.8e-05	0.00023	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—SLC22A1—prostate cancer	3.77e-05	0.000228	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PTGS2—prostate cancer	3.76e-05	0.000228	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—AKT1—prostate cancer	3.74e-05	0.000226	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	3.72e-05	0.000225	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—SULT2A1—prostate cancer	3.67e-05	0.000222	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—MED12—prostate cancer	3.61e-05	0.000219	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—GNG5—prostate cancer	3.58e-05	0.000217	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—NCOA3—prostate cancer	3.45e-05	0.000209	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	3.39e-05	0.000205	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—HPGDS—prostate cancer	3.29e-05	0.000199	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PTEN—prostate cancer	3.28e-05	0.000199	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—CYP2C19—prostate cancer	3.27e-05	0.000198	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—ACHE—prostate cancer	3.19e-05	0.000193	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—GSTT1—prostate cancer	3.19e-05	0.000193	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—CYP2A6—prostate cancer	3.16e-05	0.000191	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	3.14e-05	0.00019	CbGpPWpGaD
Carbimazole—TPO—Metabolism—EP300—prostate cancer	3.13e-05	0.000189	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—AKR1C3—prostate cancer	3.07e-05	0.000186	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PRKACB—prostate cancer	3.05e-05	0.000185	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—CYP17A1—prostate cancer	3.02e-05	0.000183	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	2.98e-05	0.00018	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—NCOA2—prostate cancer	2.88e-05	0.000174	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—SLC5A5—prostate cancer	2.75e-05	0.000166	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—CYP2E1—prostate cancer	2.68e-05	0.000162	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—NQO1—prostate cancer	2.65e-05	0.000161	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—TH—prostate cancer	2.62e-05	0.000158	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	2.6e-05	0.000157	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—CYP3A4—prostate cancer	2.59e-05	0.000157	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	2.57e-05	0.000156	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—CYP1B1—prostate cancer	2.54e-05	0.000154	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—GGT1—prostate cancer	2.46e-05	0.000149	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—NCOA1—prostate cancer	2.43e-05	0.000147	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PIK3CA—prostate cancer	2.31e-05	0.00014	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—RXRA—prostate cancer	2.31e-05	0.00014	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	2.25e-05	0.000136	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—COMT—prostate cancer	2.22e-05	0.000135	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—GSTP1—prostate cancer	2.21e-05	0.000134	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—ITPR1—prostate cancer	2.18e-05	0.000132	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—EP300—prostate cancer	2.14e-05	0.00013	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—TYMS—prostate cancer	2.06e-05	0.000125	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—GSTM1—prostate cancer	2.03e-05	0.000123	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—LPL—prostate cancer	2e-05	0.000121	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—CYP1A1—prostate cancer	1.93e-05	0.000117	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—ERCC2—prostate cancer	1.91e-05	0.000116	CbGpPWpGaD
Carbimazole—TPO—Metabolism—AKT1—prostate cancer	1.89e-05	0.000114	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—MTHFR—prostate cancer	1.8e-05	0.000109	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PPARA—prostate cancer	1.76e-05	0.000107	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—CAV1—prostate cancer	1.66e-05	0.0001	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.58e-05	9.59e-05	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PIK3CG—prostate cancer	1.51e-05	9.14e-05	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—INS—prostate cancer	1.43e-05	8.65e-05	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—CREBBP—prostate cancer	1.4e-05	8.47e-05	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PIK3CD—prostate cancer	1.33e-05	8.03e-05	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—NOS3—prostate cancer	1.25e-05	7.59e-05	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PIK3CB—prostate cancer	1.16e-05	7e-05	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PTGS2—prostate cancer	1.15e-05	6.94e-05	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PTEN—prostate cancer	1e-05	6.05e-05	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—EP300—prostate cancer	9.54e-06	5.77e-05	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PIK3CA—prostate cancer	7.05e-06	4.27e-05	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—AKT1—prostate cancer	5.76e-06	3.49e-05	CbGpPWpGaD
